Rationally-designed anti-mullerian inhibiting substance type II receptor antibodies

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9611321
APP PUB NO 20140234213A1
SERIAL NO

14122286

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Methods for generating hybrid antibodies are provided.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
FOX CHASE CANCER CENTER7701 BURHOLME AVENUE PHILADELPHIA PA 19111

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Adams, Gregory P Hatboro, US 15 422
Dunbrack, Roland Philadelphia, US 7 49
Lehmann, Andreas Bear, US 29 116
Robinson, Matthew K Blue Bell, US 14 33
Simmons, Heidi H Willow Grove, US 3 8

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Oct 4, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00